Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,235 | N/A | N/A | N/A | -4,893 |
| Depreciation Amortization | 6 | N/A | N/A | N/A | 8 |
| Accounts receivable | 1,728 | N/A | N/A | N/A | -1,230 |
| Accounts payable and accrued liabilities | -1,857 | N/A | N/A | N/A | -238 |
| Other Working Capital | -344 | N/A | N/A | N/A | -941 |
| Other Operating Activity | 214 | 0 | 0 | 0 | 1,712 |
| Operating Cash Flow | $-8,488 | $N/A | $N/A | $N/A | $-5,582 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -1 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-1 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,850 | N/A | N/A | N/A | 10,168 |
| Financing Cash Flow | $14,850 | $N/A | $N/A | $N/A | $10,168 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 2 |
| Beginning Cash Position | 2,697 | N/A | N/A | N/A | 3,615 |
| End Cash Position | 9,059 | N/A | N/A | N/A | 8,202 |
| Net Cash Flow | $6,362 | $N/A | $N/A | $N/A | $4,587 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,488 | N/A | N/A | N/A | -5,582 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -1 |
| Free Cash Flow | -8,488 | 0 | 0 | 0 | -5,583 |